Orange Byte B.V. – Trademark Portfolio
Entity Type: 98
Orange Byte B.V. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 45 (Legal & Security Services) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include M2POINT and FANSPIRAL.
Binderij 7U
NL-1185 NH Amstelveen
Showing of trademarks Trademarks
Trademark Classifications
Orange Byte B.V.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Legal services; security services for the protection of property and individuals
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Orange Byte B.V. have?
Orange Byte B.V. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Orange Byte B.V. file in?
Orange Byte B.V. files trademarks across 4 Nice Classification classes. The most active classes are Class 45 (Legal & Security Services), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial). Class 45 covers legal services; security services for the protection of property and individuals.
What are Orange Byte B.V.'s most well-known trademarks?
Orange Byte B.V.'s registered trademark portfolio includes well-known marks such as M2POINT and FANSPIRAL. These are among 3 currently registered trademarks in the portfolio.
What is Orange Byte B.V.'s trademark registration success rate?
Orange Byte B.V. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.